Nell L J, Virta V J, Thomas J W
J Clin Invest. 1985 Dec;76(6):2070-7. doi: 10.1172/JCI112210.
Structurally defined proteins and peptides have provided considerable information about the specificity and regulation of immune responses in inbred animals. Many diabetics require therapy with insulin; therefore, we used this defined protein as a model antigen to investigate immune responses in the outbred human population. In this report, we examine human T cell recognition of antigenic determinants on various insulins. A group of 25 subjects was selected from over 200 diabetics because of the magnitude of their in vitro responses. 13 of the 25 had significant T cell responses to human insulin despite treatment with only beef/pork insulin mixtures. This autoimmunity may be attributed to crossreactivity of lymphocytes highly reactive to "foreign" epitopes on therapeutic insulins. Alternatively, identical determinants shared by human and animal insulins may be recognized. By employing additional insulins not used therapeutically and isolated A and B chains, several potential mechanisms for lymphocyte autoreactivity to human insulin were demonstrated. Some epitopes are conformational and require recognition of an intact molecule, whereas other epitopes may arise from antigen processing at the cellular level. Studies using zinc-free insulins suggest that zinc-induced alterations of the molecular surface may result in some shared reactivities between animal and human insulin. Furthermore, T cell reactivity against "foreign" epitopes is more complex than anticipated from differences in amino acid sequence. The response patterns of many subjects indicate that the A-chain loop associates with the N-terminal B chain to form a complex determinant. This determinant is recognized more often than individual amino acids. We conclude that insulin therapy generates polyclonal T cell responses directed at multiple epitopes on the molecule. Many of these epitopes are not identified by amino acid exchanges and their presence on human insulin leads to apparent autoimmunity.
结构明确的蛋白质和肽为近交系动物免疫反应的特异性和调节提供了大量信息。许多糖尿病患者需要胰岛素治疗;因此,我们将这种结构明确的蛋白质用作模型抗原,以研究远交人群中的免疫反应。在本报告中,我们研究了人类T细胞对各种胰岛素上抗原决定簇的识别。从200多名糖尿病患者中挑选出25名受试者,原因是他们体外反应的强度。25名受试者中有13名尽管仅接受牛肉/猪肉胰岛素混合物治疗,但对人胰岛素仍有显著的T细胞反应。这种自身免疫可能归因于对治疗性胰岛素上“外来”表位高度反应的淋巴细胞的交叉反应性。或者,可能识别出人和动物胰岛素共有的相同决定簇。通过使用未用于治疗的其他胰岛素以及分离的A链和B链,证明了淋巴细胞对人胰岛素自身反应性的几种潜在机制。一些表位是构象性的,需要识别完整分子,而其他表位可能源于细胞水平的抗原加工。使用无锌胰岛素的研究表明,锌诱导的分子表面改变可能导致动物和人胰岛素之间存在一些共同的反应性。此外,T细胞对“外来”表位的反应性比从氨基酸序列差异预期的更为复杂。许多受试者的反应模式表明,A链环与N端B链结合形成一个复杂的决定簇。这个决定簇比单个氨基酸更常被识别。我们得出结论,胰岛素治疗会产生针对分子上多个表位的多克隆T细胞反应。这些表位中的许多不能通过氨基酸交换来识别,它们在人胰岛素上的存在导致明显的自身免疫。